6533b81ffe1ef96bd1278839

RESEARCH PRODUCT

Evaluation of socket healing in patients undergoing bisphosphonate therapy: experience of a single Institution

Fábio De Abreu AlvesRodrigo Nascimento LopesGabriel Fukunaga KatoGraziella Chagas JaguarAna Paula Da Silva

subject

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentDentistryOdontologíaCohort StudiesmedicineHumansTooth SocketGeneral DentistryDental alveolusAgedRetrospective StudiesAged 80 and overUnivariate analysisWound HealingDiphosphonatesbusiness.industryCancerRetrospective cohort studyBisphosphonateMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryOtorhinolaryngologyTooth ExtractionUNESCO::CIENCIAS MÉDICASCorticosteroidSurgeryFemaleResearch-ArticleOdontostomatology for the Disabled or Special PatientsbusinessOsteonecrosis of the jawCohort study

description

Objective: To assess the clinical features of exodontias performed in cancer patients who have been receiving intravenous bisphosphonates (BPs). Study Design: This is a retrospective cohort study using a sample of 20 patients receiving BPs who had 62 teeth extracted. An univariate analysis was applied to calculate socket healing time (HT), comparing among exodontias performed according to cause, such as periodontal disease or caries, type of BP, and use of corticosteroid. In order to analyze the influence of each variable on HT, multiple statistical analyses were performed through logistic multiple regression. Results: From the 62 tooth extractions performed, 5 exodontias had evolved to 4 sites of bisphosphonate-related osteonecrosis of the jaws (BOJ). Of another 57 exodontias without development of BOJ, HT was significantly better for tooth extraction performed in patients receiving corticosteroid (p= .01), for tooth extracted due to caries (p= .04), and for extractions under pamidronate (p= .03). Sockets after exodontias due to periodontal diseases had OR= 5.22 (95% CI 1.73-133.66, p=0.01) for delayed HT, exodontias performed under corticosteroid use had OR=0.04 (95% CI 0.01-0.40, p<0.001), and exodontias performed under zoledronate had OR=0.31 (95% CI 0.08-1.25, p=0.10). Conclusions: Exodontias performed in patients under BP therapy had a low rate of BOJ occurrence. Zoledronate and periodontal diseases influence delayed socket healing. Adjuvant antibiotics could be relevant procedures aimed at reducing the risk of BOJ development. Key words:Bisphosphonate; tooth extraction; osteonecrosis; jaw osteonecrosis; bisphosphonate-related osteonecrosis; socket healing.

http://hdl.handle.net/10550/35638